Novel Drug May Help Speed Kids' GI Recovery in Severe Post-COVID Syndrome

(MedPage Today) — Adding a novel oral drug originally designed to treat celiac disease to standard treatment for post-COVID multisystem inflammatory syndrome in children (MIS-C) appeared safe and effective in a small, phase IIa randomized, double…

Source link : https://www.medpagetoday.com/infectiousdisease/covid19/116754

Author :

Publish date : 2025-07-30 20:49:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Novel Drug May Help Speed Kids’ GI Recovery in Severe Post-COVID Syndrome

Medical Student Survey: How US Budget Bill Affects You

ECG Quirks Spotted After Gender-Affirming Hormone Therapy

Related Posts

Where Are U.S. Antibiotics Originating? Aldosterone and Heart Disease Risk

Pronatalism and Public Health Are Incompatible

Poor Heart Health in Youth Linked With Later Pregnancy Risks

Report shows ‘stark’ gender gap in HIV prevention across West Midlands

GLP 1s and Libido: An Effect That May Fly Under the Radar

Starving Children Screaming for Food as U.S. Aid Cuts Unleash Devastation and Death

Where Are U.S. Antibiotics Originating? Aldosterone and Heart Disease Risk

Pronatalism and Public Health Are Incompatible

Poor Heart Health in Youth Linked With Later Pregnancy Risks

Report shows ‘stark’ gender gap in HIV prevention across West Midlands

GLP 1s and Libido: An Effect That May Fly Under the Radar

Starving Children Screaming for Food as U.S. Aid Cuts Unleash Devastation and Death

Could Oral Microbiome Test Indicate Pancreatic Cancer Risk?

Trump Administration Begins Firing Federal Health Workers Amid Shutdown

Categories

Archives